Qube Research & Technologies (QRT)
DICE

Qube Research & Technologies (QRT)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-114,335
Closed -$5.31M – 4412
2023
Q2 		$5.31M Buy
+114,335
New +$3.95M 0.02% 689
2022
Q3 		– Sell
-17,903
Closed -$278K – 3202
2022
Q2 		$278K Buy
+17,903
New +$308K ﹤0.01% 1614
2021
Q4 		– Sell
-6,788
Closed -$222K – 3109
2021
Q3 		$222K Buy
+6,788
New +$231K ﹤0.01% 1614

Qube Research & Technologies (QRT)'s DICE Position: Q3 2023 in Review

Qube Research & Technologies (QRT) sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 114,335 shares — an estimated $5.31M sold.

Qube Research & Technologies (QRT) first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $5.31M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Qube Research & Technologies (QRT) reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 114,335 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $5.31M.
  • Qube Research & Technologies (QRT) first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s DICE Therapeutics, Inc. Common Stock position peaked at $5.31M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.